In a new study, Broad Institute researchers report that two small-molecule chemicals that reduce oxygen delivery to cells ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...

Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Revolution Medicines on Wednesday, Aug. 26, 2026 shows packaging for the new pancreatic cancer drug, ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S.

The Food and Drug Administration on Wednesday rubber-stamped a new drug to treat pancreatic cancer and substantially extend the lives of patients. The drug, daraxonrasib, is produced by Revolution ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder. By Carolyn Y. Johnson Many people have a cartoonish idea of narcolepsy, perhaps picturing someone ...

Jeffrey Alford had been living in active addiction for five years when, in August 2020, he was arrested on a felony charge of possession of a Schedule II drug and booked at the Jefferson Parish jail.

The typical price for a newly approved prescription drug has surpassed $250,000, a new study shows, reflecting rising costs ...

Efforts to bring down Scotland's sky-high rate of drug deaths are being frustrated by the arrival of hundreds of powerful new synthetic substances that experts warn are making the deadly drugs crisis ...

An update to this study of ICER has been published here, thanks to conversation with and insight from Mitchell Stein, policy and communications director at ICER, who clarified the differences between ...